A field investigation of an African horse sickness outbreak in the controlled area of South Africa in 2016

Loading...
Thumbnail Image

Authors

Grewar, John Duncan
Weyer, Camilla Theresa
Venter, Gert Johannes
Van Helden, Lesley Susan
Burger, Phillippa
Guthrie, Alan John
Coetzee, Peter
Labuschagne, Karien
Buhrmann, Gary
Parker, Beverley Joan

Journal Title

Journal ISSN

Volume Title

Publisher

Wiley

Abstract

An outbreak of African horse sickness (AHS) caused by AHS virus type 1 occurred within the South African AHS surveillance zone during April and May 2016. The index case was detected by a private veterinarian through passive surveillance. There were 21 cases in total, which is relatively low compared to case totals during prior AHS outbreaks in the same region (and of the same AHS virus type) in 2004, 2011 and 2014. The affected proportion of horses on affected properties was 0.07 (95% CI 0.04, 0.11). Weather conditions were conducive to high midge activity immediately prior to the outbreak but midge numbers decreased rapidly with the advent of winter. The outbreak was localized, with 18 of the 21 cases occurring within 8 km of the index property and the three remaining cases on two properties within 21 km of the index property, with direction of spread consistent with wind‐borne dispersion of infected midges. Control measures included implementation of a containment zone with movement restrictions on equids. The outbreak was attributed to a reversion to virulence of a live attenuated vaccine used extensively in South Africa. Outbreaks in the AHS control zones have a major detrimental impact on the direct export of horses from South Africa, notably to the European Union.

Description

Keywords

African horse sickness type 1, African horse sickness (AHS), Culicoides, Disease outbreak, Horse (Equus caballus), South Africa (SA)

Sustainable Development Goals

Citation

Grewar JD, Weyer CT, Venter GJ, et al. A field investigation of an African horse sickness outbreak in the controlled area of South Africa in 2016. Transboundary and Emerging Diseases 2019;66:743–751. https://doi.org/10.1111/tbed.13077.